138 related articles for article (PubMed ID: 37423426)
1. Clinical, biological and genome-wide comparison of carbapenem-resistant Klebsiella pneumoniae with susceptibility transformation to polymyxin B during therapy.
Wang Y; Luo Q; Chen T; Chi X; Zhou Y; Fu H; Lu P; Xiong L; Xiao T; Zheng B; Shen P; Xiao Y
Clin Microbiol Infect; 2023 Oct; 29(10):1336.e1-1336.e8. PubMed ID: 37423426
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
Tian Y; Zhang Q; Wen L; Chen J
Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
[TBL] [Abstract][Full Text] [Related]
3. Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Vieceli T; Henrique LR; Rech TH; Zavascki AP
J Infect Chemother; 2024 Jul; 30(7):621-625. PubMed ID: 38244722
[TBL] [Abstract][Full Text] [Related]
4. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
J Glob Antimicrob Resist; 2022 Sep; 30():357-362. PubMed ID: 35817263
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study.
Luo Q; Xu L; Wang Y; Fu H; Xiao T; Yu W; Zhou W; Zhang K; Shen J; Ji J; Ying C; Xiao Y
Clin Microbiol Infect; 2024 Apr; 30(4):507-514. PubMed ID: 38295990
[TBL] [Abstract][Full Text] [Related]
6. Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains.
Adaleti R; Nakipoğlu Y; Çalık Ş; Arıcı N; Kansak N; Şenbayrak S; Aksaray S
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):155-160. PubMed ID: 37133999
[TBL] [Abstract][Full Text] [Related]
7. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy.
Zavascki AP; Girardello R; Magagnin CM; Antochevis LC; Maciel RA; Palmeiro JK; Gales AC
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):134-138. PubMed ID: 29150371
[TBL] [Abstract][Full Text] [Related]
8. BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.
Liang Z; Shi YL; Peng Y; Xu C; Zhang C; Chen Y; Luo XQ; Li QM; Zhao CL; Lei J; Yuan ZQ; Peng YZ; Song BQ; Gong YL
Virus Res; 2023 Jul; 331():199126. PubMed ID: 37105436
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
[TBL] [Abstract][Full Text] [Related]
10. Resistance evolution of hypervirulent carbapenem-resistant
Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
Su S; Zhang J; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Li C; Zhang X
BMC Infect Dis; 2020 Jul; 20(1):472. PubMed ID: 32616018
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant hypermucoviscous
Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
[TBL] [Abstract][Full Text] [Related]
14. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
Borjan J; Meyer KA; Shields RK; Wenzler E
Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
[TBL] [Abstract][Full Text] [Related]
15. A Study of the Virulence Traits of Carbapenem-Resistant
Khalil MAF; Hager R; Abd-El Reheem F; Mahmoud EE; Samir T; Moawad SS; Hefzy EM
Microb Drug Resist; 2019 Sep; 25(7):1063-1071. PubMed ID: 31033413
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Carbapenem-Resistant
Liao W; Huang N; Zhang Y; Sun Y; Chen T; Zeng W; Chen L; Wen H; Cao J; Zhou T
Front Public Health; 2021; 9():783124. PubMed ID: 34926395
[TBL] [Abstract][Full Text] [Related]
17. [Molecular epidemiological characterization of hypervirulent carbapenem-resistant
Liu XW; Li DZ; Hu Y; Zhu R; Liu DM; Guo MY; Ren YY; Li YF; Li YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Aug; 57(8):1222-1230. PubMed ID: 37574316
[No Abstract] [Full Text] [Related]
18. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
Zhang X; Qu F; Jia W; Huang B; Shan B; Yu H; Tang Y; Chen L; Du H
Int J Antimicrob Agents; 2021 Feb; 57(2):106262. PubMed ID: 33347990
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
Zhao H; He Z; Li Y; Sun B
BMC Microbiol; 2022 Nov; 22(1):262. PubMed ID: 36319965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
